BioCentury
ARTICLE | Financial News

New AZN CEO suspends share repurchase program

October 2, 2012 1:29 AM UTC

AstraZeneca plc (LSE:AZN; NYSE:AZN) CEO Pascal Soriot suspended the company's share repurchase program on his first day of employment Monday. Soriot, who was COO of the pharmaceuticals division at Roc...